Aduro Biotech is categorized under Commercial Physical Research in Berkeley, CA and active since 2008.
Aduro Biotech was established in 2008, and today employs 1 to 4, earning Unknown per year. This is a Commercial Physical Research business, which does work in the B2B market, and is classified as a Commercial Physical Research, under code number 5417114 by the NAICS.
If you are seeking more information, feel free to contact Stephen Isaacs, Chief Executive Officer at the company’s single location by writing to 626 Bancroft Way # 3c, Berkeley, California CA 94710 or by phoning (510) 848-4400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Aduro Biotech |
| Contact Person: | Stephen Isaacs, Chief Executive Officer |
| Address: | 626 Bancroft Way # 3c, Berkeley, California 94710 |
| Phone Number: | (510) 848-4400 |
| Website Address: | adurobiotech.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Physical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5417114 |
| Share This Business: |
Aduro Biotech was started in 2008 to provide professional Commercial Physical Research under the SIC code 8731 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Stephen Isaacs, Chief Executive Officer for inquiries that concern Aduro Biotech by calling the company number (510) 848-4400, as your correspondence is most welcome. Additionally, the physical location of the single location of Aduro Biotech can be found at the coordinates 37.86277,-122.2996 as well as the street address 626 Bancroft Way # 3c in Berkeley, California 94710.
For its online presence, you may visit Aduro Biotech’s website at adurobiotech.com and engage with its social media outlets through on Twitter and on Facebook.